Literature DB >> 11520766

Pentoxifylline influences the autocrine function of organ cultured donor corneas and enhances endothelial cell survival.

A C Ventura1, M Böhnke.   

Abstract

BACKGROUND/AIMS: Scientific interest in pentoxifylline has been reawakened owing to the recognised effects of this drug on immune functions, particularly its influence on cytokine production. In a previous study, the authors demonstrated that spiking of organ culture media with endotoxin elicited a marked enhancement in the release of IL-6 and IL-8 from corneal tissue and that these events coincided with degenerative changes in endothelial cells and a higher incidence of actual loss among this population. Since traces of donor derived endotoxin can be detected in up to 50% of corneal organ cultures, this substance may have a direct influence on graft viability or trigger inflammatory responses in the host. They, therefore, wished to ascertain whether supplementation of media with pentoxifylline improved endothelial cell survival in organ cultured donor corneas.
METHODS: 12 fellow pairs of donor corneas were cultured for 20 days, with a change of medium on day 10: One of each pair was incubated in the absence, and the other in the presence, of pentoxifylline (25 microg/ml). Samples of medium were withdrawn at regular intervals during the course of incubation and screened for cytokines IL-6, IL-8, and prostaglandin E2 by ELISA. Endothelial cell morphology and numerical density were assessed on days 0, 10 and 20.
RESULTS: Addition of pentoxifylline to organ culture media led to a significant improvement in endothelial cell survival. This drug also elicited a significant increase in the level of IL-6 and marginally suppressed that of IL-8 during the initial 10 day phase of incubation. During the second 10-20 day phase, the level of both IL-6 and IL-8 decreased significantly in the presence of pentoxifylline, the relation between these two cytokines being the inverse of that observed in the absence of the drug. No significant changes in the level of prostaglandin E2 were apparent.
CONCLUSION: The addition of pentoxifylline to organ culture media leads, ultimately, to a suppression of IL-6 and IL-8 secretion by corneal tissue. The potentially damaging effects of these cytokines are thereby quelled, as evidenced by the improvement in endothelial cell survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520766      PMCID: PMC1724110          DOI: 10.1136/bjo.85.9.1110

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  38 in total

1.  Effects on complement activation and cytokine (TNF-alpha and IL-8) release of infusion of anti-TNF-antibodies or a xanthine derivative (HWA 138) in septic baboons.

Authors:  A Bengtsson; H Redl; G Schlag; T E Mollnes; K Högåsen
Journal:  Acta Anaesthesiol Scand       Date:  1996-02       Impact factor: 2.105

2.  Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.

Authors:  J Navarro; M C Punzón; A Pizarro; E Fernández-Cruz; M Fresno; M A Muñoz-Fernández
Journal:  AIDS       Date:  1996-05       Impact factor: 4.177

3.  Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline.

Authors:  C L D'Hellencourt; L Diaw; P Cornillet; M Guenounou
Journal:  Int J Immunopharmacol       Date:  1996-12

4.  In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.

Authors:  J M Reimund; S Dumont; C D Muller; J S Kenney; M Kedinger; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

5.  Different regulatory effects of pentoxifylline on human T cell activation pathways.

Authors:  R P Dong; Y Umezawa; H Ikushima; Y Munakata; S F Schlossman; C Morimoto
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

6.  Polymorphonuclear leukocyte myeloperoxidase levels in patients with Behçet's disease.

Authors:  A Accardo-Palumbo; G Triolo; M C Carbone; A Ferrante; F Ciccia; E Giardina; G Triolo
Journal:  Clin Exp Rheumatol       Date:  2000 Jul-Aug       Impact factor: 4.473

7.  Pentoxifylline inhibits granzyme B and perforin expression following T-lymphocyte activation by anti-CD3 antibody.

Authors:  D W Hoskin; T Phu; A P Makrigiannis
Journal:  Int J Immunopharmacol       Date:  1996-11

8.  Modulation of reperfusion injury after single lung transplantation by pentoxifylline, inositol polyanions, and sin-1.

Authors:  S C Clark; C Sudarshan; J Roughan; P A Flecknell; J H Dark
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

9.  Effects of pentoxifylline in endotoxinemia in human volunteers.

Authors:  P Zabel; M M Schönharting; U F Schade; M Schlaak
Journal:  Prog Clin Biol Res       Date:  1991

10.  Human corneal interleukin-8. IL-1 and TNF-induced gene expression and secretion.

Authors:  V M Elner; R M Strieter; M A Pavilack; S G Elner; D G Remick; J M Danforth; S L Kunkel
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more
  1 in total

1.  Glutaraldehyde cross-linking of amniotic membranes affects their nanofibrous structures and limbal epithelial cell culture characteristics.

Authors:  Jui-Yang Lai; David Hui-Kang Ma
Journal:  Int J Nanomedicine       Date:  2013-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.